
Melanoma Matters
Ep 88: Negative Adjuvant Doublet Studies (CM915, KV010, RELA098)
September 1, 202622 min
Melanoma Matters: Why Adjuvant Doublet Immunotherapy Fell Short Hobbies - James wishes he was surfing more This episode breaks down three negative adjuvant melanoma trials testing combination immunotherapy against anti PD 1 monotherapy. The discussion focuses on why toxicity rises without clear efficacy gains, and what these results mean for adjuvant and neoadjuvant strategy going forward. James Larkin and Sapna Patel also dig into a bigger question: if combination therapy helps in metastatic disease, why does it seem to lose its edge in microscopic or...
No transcript for this episode yet
You can still listen to it in the player. On episodes with a transcript, you can tap any word to see its meaning.